AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

NEKTAR THERAPEUTICS Director's Dealing 2021

Dec 21, 2021

32134_dirs_2021-12-20_21f252a0-24b5-4c1b-aa2f-c903d0b12526.zip

Director's Dealing

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2021-11-15

Reporting Person: Labrucherie Gil M (SVP, COO & CFO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	280381	Direct